Human dermal fibroblasts in psychiatry research

Area of Science:

• Neuroscience
• Genetics
• Cell Biology

Background:

• Multifactorial human brain diseases require diverse experimental models for etiology, progression, and treatment research.
• Patient-derived human dermal fibroblast (HDF) cultures are emerging as a valuable in vitro system for studying psychiatric disorders.
• HDF studies complement traditional postmortem and animal models, providing insights into neural tissue homeostasis.

Purpose of the Study:

• To highlight the utility of HDF cultures as a model for investigating the cellular, molecular, and physiological aspects of psychiatric disorders.
• To demonstrate the potential of HDF models in understanding disease mechanisms, including signal transduction, redox homeostasis, circadian rhythms, and gene*environment interactions.
• To explore the diagnostic and prognostic potential of HDFs in psychiatric disorders, including predicting therapeutic responses.

Main Methods:

• Utilizing patient-derived human dermal fibroblast (HDF) cultures.
• Applying modern molecular biology techniques to analyze HDFs.
• Examining cellular, molecular, metabolic, and (patho)physiological states and traits relevant to psychiatric disorders.

Main Results:

• HDF studies have significantly advanced the understanding of schizophrenia, depression, bipolar disorder, autism, and ADHD.
• HDF models are effective in assessing signal transduction, redox homeostasis, circadian rhythms, and gene*environment interactions.
• Findings suggest HDFs have potential diagnostic and prognostic value, including predicting treatment response.

Conclusions:

• HDF cultures represent a powerful and underutilized in vitro model for psychiatric disorder research.
• HDF analysis can provide crucial information on disease mechanisms and altered homeostasis in neural tissue.
• This patient biomaterial holds promise for diagnostic, prognostic, and therapeutic prediction in psychiatric disorders.